These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 39051072

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Association between triglyceride glucose-body mass index and the staging of non-alcoholic steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.
    Zhang F, Han Y, Wu Y, Bao Z, Zheng G, Liu J, Li W.
    Ann Med; 2024 Dec; 56(1):2409342. PubMed ID: 39348274
    [Abstract] [Full Text] [Related]

  • 4. Triglyceride-glucose index and combined indicators: effective indicators for screening NAFLD in snoring patients.
    Cai Y, Chen J, Deng X, Wang B, Huang J, Lian N.
    BMC Pulm Med; 2024 Jul 24; 24(1):359. PubMed ID: 39049008
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population.
    Hu H, Han Y, Cao C, He Y.
    J Transl Med; 2022 Sep 05; 20(1):398. PubMed ID: 36064712
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the ability of insulin resistance and lipid-related indices to predict the presence of NAFLD in obese adolescents.
    Yetim A, Şahin M, Kandemir İ, Bulakçı B, Aksakal MT, Karapınar E, Sever H, Baş F.
    Lipids Health Dis; 2024 Jul 02; 23(1):208. PubMed ID: 38956572
    [Abstract] [Full Text] [Related]

  • 8. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults.
    Li S, Feng L, Ding J, Zhou W, Yuan T, Mao J.
    BMC Gastroenterol; 2023 Nov 02; 23(1):376. PubMed ID: 37919650
    [Abstract] [Full Text] [Related]

  • 9. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease.
    Chen Q, Hu P, Hou X, Sun Y, Jiao M, Peng L, Dai Z, Yin X, Liu R, Li Y, Zhu C.
    Cardiovasc Diabetol; 2024 Jul 04; 23(1):232. PubMed ID: 38965572
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Non-alcoholic fatty liver disease in Tanzania: prevalence, determinants, and diagnostic performance of triglycerides-glucose index and triglycerides-glucose index -body mass index compared to the hepatic ultrasound in overweight and obese individuals.
    Kilonzo SB, Kamala E, Jaka H, Ngoya P.
    BMC Gastroenterol; 2024 Mar 04; 24(1):96. PubMed ID: 38438930
    [Abstract] [Full Text] [Related]

  • 16. Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999-2018.
    Zhang Y, Wang F, Tang J, Shen L, He J, Chen Y.
    Cardiovasc Diabetol; 2024 Jul 18; 23(1):262. PubMed ID: 39026233
    [Abstract] [Full Text] [Related]

  • 17. Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People.
    Otsubo N, Fukuda T, Cho G, Ishibashi F, Yamada T, Monzen K.
    Intern Med; 2023 Aug 15; 62(16):2307-2319. PubMed ID: 36517035
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic Performance of Insulin Resistance Indices for Identifying Metabolic Dysfunction-Associated Fatty Liver Disease.
    Han AL, Lee HK, Shin SR.
    Metab Syndr Relat Disord; 2024 Jun 15; 22(5):402-409. PubMed ID: 38574322
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population.
    Zeng P, Cai X, Yu X, Gong L.
    Sci Rep; 2023 Nov 22; 13(1):20470. PubMed ID: 37993481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.